Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | and similar dates through November 2027
Funding Amounts: Up to $499,000 direct costs per year, for up to 5 years (R01 mechanism; no clinical trials allowed)
Summary: Supports academic-industrial partnerships to translate technologies for diagnosis and treatment, with a focus on cancer and related diseases; clinical trials are not permitted.
Key Information: Requires at least one academic and one industrial partner; open to U.S. and non-U.S. organizations; projects must emphasize translation, not basic research or commercial production.
This funding opportunity from the National Institutes of Health (NIH), led by the National Cancer Institute (NCI) and joined by the National Eye Institute (NEI) and National Institute of Dental and Craniofacial Research (NIDCR), aims to stimulate academic-industrial partnerships that translate scientific discoveries and engineering developments into practical methods or tools for disease diagnosis, treatment, and management. The program is designed to bridge gaps between academic and industrial expertise, supporting interdisciplinary, multi-institutional teams to develop, adapt, optimize, and validate technologies for end-user application in pre-clinical, clinical, or non-clinical settings.
Projects must focus on translational research—moving a technology, method, assay, device, or system from proof-of-concept to a state ready for use in the intended setting. The definition of "innovation" for this opportunity is broad, emphasizing the likelihood of delivering a new capability to end users, including in low-resource or underserved settings.
Clinical trials are not allowed under this opportunity.
Eligible organizations include:
Key requirements:
Submission: Electronic submission via Grants.gov, NIH ASSIST, or institutional system-to-system solutions.
Required registrations: SAM, eRA Commons, Grants.gov, and (for foreign organizations) NCAGE code.
Application format: Follow the NIH SF424 (R&R) Application Guide and the specific instructions in the funding announcement.
Key application components:
Review criteria: Scientific significance, innovation (as defined by likelihood to deliver new capability), rigor and feasibility, expertise and resources, and partnership structure.
Contact Type | Name/Title | Institute/Office | Phone | |
---|---|---|---|---|
Scientific/Research Contact | Miguel R. Ossandon, Ph.D. | NCI | ossandom@mail.nih.gov | 240-276-5714 |
Scientific/Research Contact | Darrell Tata, Ph.D. | NCI | Darrell.tata@nih.gov | 240-781-3315 |
Scientific/Research Contact | Rao L. Divi, Ph.D. | NCI | divir@dc37a.nci.nih.gov | 240-276-6913 |
Scientific/Research Contact | Benjamin Philip Johns, Ph.D. | ORWH | benjamin.johns@nih.gov | 301-435-1681 |
Scientific/Research Contact | Zhong Chen, M.D., Ph.D. | NIDCR | zhong.chen@nih.gov | 301-529-7083 |
Scientific/Research Contact | Tony Douglas Gover | NEI | tony.gover@nih.gov | 301-529-7370 |
Peer Review Contact | Dr. Lambratu Rahman Sesay | Center for Scientific Review | rahman-sesay@csr.nih.gov | 301-905-8294 |
Grants Management Contact | Shane Woodward | NCI | woodwars@mail.nih.gov | 240-276-6303 |
Grants Management Contact | Gabriel Hidalgo | NIDCR | hidalgoge@mail.nih.gov | 301-827-4630 |
Grants Management Contact | Karen Robinson Smith | NEI | kyr@nei.nih.gov | 301-435-8178 |
General Grants Info | NIH Grants Information | NIH | GrantsInfo@nih.gov | 301-480-7075 |
Application Support | eRA Service Desk | NIH | https://www.era.nih.gov/need-help | 301-402-7469 or 866-504-9552 |
Grants.gov Support | Grants.gov Customer Support | Grants.gov | support@grants.gov | 800-518-4726 |